Anthropic, OpenEvidence Partner to Expand Medical AI Access Globally
According to reports, AI startup Anthropic and medical knowledge platform OpenEvidence are partnering to provide AI-driven clinical decision support to doctors in areas lacking access to this technology.
OpenEvidence addresses physicians' inquiries by utilizing peer-reviewed medical studies and treatment protocols. The platform is available at no cost to healthcare professionals in the United States and Europe.
The new initiative offers a tailored version at no cost to healthcare providers in numerous low- and middle-income countries, where restricted access to medical literature, specialist knowledge, and ongoing medical education can hinder patient care.
Healthcare systems globally are investigating if generative AI can aid in tackling the shortfall of doctors and specialists.
Proponents claim that AI technologies can assist healthcare professionals in swiftly managing extensive medical data, whereas opponents warn that systems developed mainly on data from wealthy nations may not accurately represent local healthcare practices.
The program is being implemented in approximately 100 nations, such as Uganda, Angola, Sudan, Haiti, and Mongolia, based on a list given by OpenEvidence.
"Geographical location should not determine access to medical knowledge," stated Daniel Nadler, the founder of OpenEvidence.
Also Read: Facebook, Instagram Recover After Brief US Outage
Last week, Reuters announced that Anthropic established a lab for physical biology research, aiming to expand its artificial intelligence goals into drug science, as public concerns about AI's reach grow, prompting some executives and lawmakers to request a halt in development.
Also Read: Trump Set to Address UN Amid Iran Conflict and Global Economic Turmoil
Anthropic and OpenEvidence did not reveal the financial details of their partnership.
According to Nadler, US clinicians accessed OpenEvidence 42 million times in August alone. By 2026, a doctor utilizing OpenEvidence to inform treatment will have assisted several hundred million Americans.
Anthropic’s technology will offer back-end assistance, whereas OpenEvidence will customize the system for various regions, considering healthcare infrastructure, according to the companies.
Also Read: Trump, Xi Seek Stable Ties Amid Rising AI, Trade and Iran Tensions
"The technology has progressed so significantly that the necessary infrastructure for (introducing OpenEvidence to low-resource areas) exists, yet the market incentives would not enable it to occur without this kind of entrepreneurial, philanthropic effort," states Anthropic president Daniela Amodei.